119 related articles for article (PubMed ID: 25196195)
1. Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease.
Burrell RC; Easter JA; Cassidy MP; Gillman KW; Olson RE; Bonacorsi SJ
J Labelled Comp Radiopharm; 2014 Aug; 57(10):600-5. PubMed ID: 25196195
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of carbon-14 and stable isotope labeled Censavudine.
Burrell RC; Bonacorsi SJ; Ortiz A; Benkovics T; Shi Z
J Labelled Comp Radiopharm; 2022 Apr; 65(4):112-122. PubMed ID: 35106813
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of stable isotope-labeled epothilone D using a degradation-reconstruction approach.
Burrell RC; Turley WA; Bonacorsi SJ
J Labelled Comp Radiopharm; 2015 Jul; 58(9):361-9. PubMed ID: 26158758
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of selective inhibition of γ-secretase by avagacestat.
Albright CF; Dockens RC; Meredith JE; Olson RE; Slemmon R; Lentz KA; Wang JS; Denton RR; Pilcher G; Rhyne PW; Raybon JJ; Barten DM; Burton C; Toyn JH; Sankaranarayanan S; Polson C; Guss V; White R; Simutis F; Sanderson T; Gillman KW; Starrett JE; Bronson J; Sverdlov O; Huang SP; Castaneda L; Feldman H; Coric V; Zaczek R; Macor JE; Houston J; Berman RM; Tong G
J Pharmacol Exp Ther; 2013 Mar; 344(3):686-95. PubMed ID: 23275065
[TBL] [Abstract][Full Text] [Related]
5. A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium.
Latli B; Hrapchak M; Gao JJ; Busacca CA; Senanayake CH
J Labelled Comp Radiopharm; 2015 Jul; 58(9):390-4. PubMed ID: 26190342
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.
Coric V; van Dyck CH; Salloway S; Andreasen N; Brody M; Richter RW; Soininen H; Thein S; Shiovitz T; Pilcher G; Colby S; Rollin L; Dockens R; Pachai C; Portelius E; Andreasson U; Blennow K; Soares H; Albright C; Feldman HH; Berman RM
Arch Neurol; 2012 Nov; 69(11):1430-40. PubMed ID: 22892585
[TBL] [Abstract][Full Text] [Related]
7. Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers.
Tong G; Wang JS; Sverdlov O; Huang SP; Slemmon R; Croop R; Castaneda L; Gu H; Wong O; Li H; Berman RM; Smith C; Albright CF; Dockens RC
Clin Ther; 2012 Mar; 34(3):654-67. PubMed ID: 22381714
[TBL] [Abstract][Full Text] [Related]
8. Radiosynthesis of a carbon-11 labeled tetrahydrobenzisoxazole derivative as a new PET probe for γ-secretase imaging in Alzheimer's disease.
Xu Z; Miao C; Dong F; Jia L; Li W; Wang M; Liu W; Zheng QH
Appl Radiat Isot; 2020 Jan; 155():108915. PubMed ID: 31590101
[TBL] [Abstract][Full Text] [Related]
9. (11)C-Labeling of a potent hydroxyethylamine BACE-1 inhibitor and evaluation in vitro and in vivo.
Nordeman P; Estrada S; Odell LR; Larhed M; Antoni G
Nucl Med Biol; 2014 Jul; 41(6):536-43. PubMed ID: 24857866
[TBL] [Abstract][Full Text] [Related]
10. Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men.
Tong G; Castaneda L; Wang JS; Sverdlov O; Huang SP; Slemmon R; Gu H; Wong O; Li H; Berman RM; Smith C; Albright C; Dockens RC
Clin Drug Investig; 2012 Nov; 32(11):761-9. PubMed ID: 23018285
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of deleobuvir, a potent hepatitis C virus polymerase inhibitor, and its major metabolites labeled with carbon-13 and carbon-14.
Latli B; Hrapchak M; Chevliakov M; Li G; Campbell S; Busacca CA; Senanayake CH
J Labelled Comp Radiopharm; 2015 May; 58(6):250-60. PubMed ID: 25964148
[TBL] [Abstract][Full Text] [Related]
13. ACS chemical neuroscience molecule spotlight on BMS-708163.
Hopkins CR
ACS Chem Neurosci; 2012 Mar; 3(3):149-50. PubMed ID: 22860183
[TBL] [Abstract][Full Text] [Related]
14. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
15. Mapping the Binding Site of BMS-708163 on γ-Secretase with Cleavable Photoprobes.
Gertsik N; Am Ende CW; Geoghegan KF; Nguyen C; Mukherjee P; Mente S; Seneviratne U; Johnson DS; Li YM
Cell Chem Biol; 2017 Jan; 24(1):3-8. PubMed ID: 28065657
[TBL] [Abstract][Full Text] [Related]
16. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat.
Tong G; Wang JS; Sverdlov O; Huang SP; Slemmon R; Croop R; Castaneda L; Gu H; Wong O; Li H; Berman RM; Smith C; Albright CF; Dockens R
Br J Clin Pharmacol; 2013 Jan; 75(1):136-45. PubMed ID: 22616739
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors.
Aubele DL; Truong AP; Dressen DB; Probst GD; Bowers S; Mattson MN; Semko CM; Sun M; Garofalo AW; Konradi AW; Sham HL; Zmolek W; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Bova MP; Hemphill SS; Basi G
Bioorg Med Chem Lett; 2011 Oct; 21(19):5791-4. PubMed ID: 21885276
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of empagliflozin, a novel and selective sodium-glucose co-transporter-2 inhibitor, labeled with carbon-14 and carbon-13.
Hrapchak M; Latli B; Wang XJ; Lee H; Campbell S; Song JJ; Senanayake CH
J Labelled Comp Radiopharm; 2014 Oct; 57(12):687-94. PubMed ID: 25332189
[TBL] [Abstract][Full Text] [Related]
19. A placebo-controlled, multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects.
Dockens R; Wang JS; Castaneda L; Sverdlov O; Huang SP; Slemmon R; Gu H; Wong O; Li H; Berman RM; Smith C; Albright CF; Tong G
Clin Pharmacokinet; 2012 Oct; 51(10):681-93. PubMed ID: 23018531
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydroquinoline sulfonamides as gamma-secretase inhibitors.
Asberom T; Bara TA; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; Parker EM; Pissarnitski DA; Song L; Zhang L; Zhao Z
Bioorg Med Chem Lett; 2007 Jan; 17(1):205-7. PubMed ID: 17046254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
